Nov 2017 $20 M No. 5 $10 to $50 million 4
Stratos Genomics Inc.: Raise no. 5, Nov 2017 × Investors in this round 4 investors had bought by the notice of Jan 9, 2018: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Washington People named in the notice Mark Kokoris · Executive Officer, Director Harold Kawaguchi · Director Heiner Dreismann · Director Lee Huntsman · Director Robert McRuer · Director Stephen Rose · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Kokoris, President & CEO. Source: SEC Form D, newest notice filed Jan 9, 2018. Read the notice at the SEC .
equity SEC Apr 2014 $30 M No. 4 $10 to $50 million 2
Stratos Genomics Inc.: Raise no. 4, Apr 2014 × Investors in this round 2 investors had bought by the notice of Jun 17, 2015: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $30 M of $30 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Washington People named in the notice Allan Stephan · Executive Officer, Director Bob McRuer · Executive Officer, Director Harold Kawaguchi · Executive Officer, Director Mark Kokoris · Executive Officer, Director Heiner Dreismann · Director Lee Huntsman · Director Stephen Rose · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allan H. Stephan, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jun 17, 2015. Read the notice at the SEC .
equity SEC Sep 2013 $2 M No. 3 $2 to $10 million 1
Stratos Genomics Inc.: Raise no. 3, Sep 2013 × Investors in this round 1 investor had bought by the notice of Sep 6, 2013: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Washington People named in the notice Allan Stephan · Executive Officer, Director Bob McRuer · Executive Officer, Director Harold Kawaguchi · Executive Officer, Director Mark Kokoris · Executive Officer, Director Heiner Dreismann · Director Lee Huntsman · Director Stephen Rose · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allan H. Stephan, President and CEO. Source: SEC Form D, newest notice filed Sep 6, 2013. Read the notice at the SEC .
equity SEC Oct 2012 $2 M No. 2 $2 to $10 million 1
Stratos Genomics Inc.: Raise no. 2, Oct 2012 × Investors in this round 1 investor had bought by the notice of Oct 16, 2012: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Washington People named in the notice Allan Stephan · Executive Officer, Director Harold Kawaguchi · Executive Officer, Director Mark Kokoris · Executive Officer, Director Bob McRuer · Director Heiner Dreismann · Director Lee Huntsman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount does not include warrants issued to certain Investors to purchase up to 128,000 shares of Common Stock.”Signed by Allan H. Stephan, President and CEO. Source: SEC Form D, newest notice filed Oct 16, 2012. Read the notice at the SEC .
equity SEC Jul 2010 $5 M No. 1 $2 to $10 million 19
Stratos Genomics Inc.: Raise no. 1, Jul 2010 × Investors in this round 19 investors had bought by the notice of Jun 7, 2016: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $29,999
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Washington People named in the notice Lee Huntsman · Executive Officer, Director Mark Kokoris · Executive Officer, Director Robert McRuer · Executive Officer, Director Allan Stephan · Director Harold Kawaguchi · Director Heiner Dreismann · Director Stephen Rose · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Dr. Heiner Dreismann · Seattle, Washington Sold in WA Remarks in the notice On fees: “Finders' Fees, represents a warrant to purchase common shares issued to the placement agent pursuant to the terms of the subject financing.”On the amounts: “Total Offering Amount includes (i) principal and accrued interest on previously issued convertible notes that converted into equity; (ii) aggregate exercise price of warrants issued upon conversion of the notes; and (iii) warrants issued as finders' fees.”Signed by Mark Kokoris, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Jun 7, 2016. Read the notice at the SEC .
equity, options SEC